ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,487.03
0.25%
Dow Jones
38,834.86
0.00%
US Dollar vs MXN
18.40912
-0.13%
Brent Oil
84.855
0.19%
Bitcoin
66,072.96
1.70%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. GeneDx Holdings Corporation (WGS)

  7. GeneDx Holdings Corporation (WGS) Noticias

WGS

GeneDx (WGS)

GeneDx Holdings Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:WGS
FechaHoraFuenteTítuloSímboloCompañía
10/06/202407:30GlobeNewswire Inc.GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal PatientsNASDAQ:WGSGeneDx Holdings Corporation
05/06/202406:00GlobeNewswire Inc.GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy PatientsNASDAQ:WGSGeneDx Holdings Corporation
22/05/202415:05GlobeNewswire Inc.GeneDx to Participate in Upcoming Investor ConferencesNASDAQ:WGSGeneDx Holdings Corporation
29/04/202415:05GlobeNewswire Inc.GeneDx Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:WGSGeneDx Holdings Corporation
23/04/202407:30GlobeNewswire Inc.GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease DatasetNASDAQ:WGSGeneDx Holdings Corporation
04/04/202415:05GlobeNewswire Inc.GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024NASDAQ:WGSGeneDx Holdings Corporation
14/03/202407:30GlobeNewswire Inc.GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of GenomicsNASDAQ:WGSGeneDx Holdings Corporation
05/03/202415:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
26/02/202415:05GlobeNewswire Inc.GeneDx to Participate in 44th Annual Cowen Health Care ConferenceNASDAQ:WGSGeneDx Holdings Corporation
23/02/202415:56Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:WGSGeneDx Holdings Corporation
20/02/202415:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WGSGeneDx Holdings Corporation
20/02/202415:26GlobeNewswire Inc.GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024NASDAQ:WGSGeneDx Holdings Corporation
01/02/202415:30GlobeNewswire Inc.GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 NASDAQ:WGSGeneDx Holdings Corporation
24/01/202415:30GlobeNewswire Inc.GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:WGSGeneDx Holdings Corporation
08/01/202407:55GlobeNewswire Inc.GeneDx Announces Preliminary 2023 Financial ResultsNASDAQ:WGSGeneDx Holdings Corporation
01/12/202307:30GlobeNewswire Inc.GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with EpilepsyNASDAQ:WGSGeneDx Holdings Corporation
28/11/202315:05GlobeNewswire Inc.GeneDx to Participate in 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:WGSGeneDx Holdings Corporation
17/11/202315:15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:WGSGeneDx Holdings Corporation
03/11/202315:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:WGSGeneDx Holdings Corporation
30/10/202315:05GlobeNewswire Inc.GeneDx Reports Third Quarter 2023 Financial Results and Business HighlightsNASDAQ:WGSGeneDx Holdings Corporation
09/10/202315:05GlobeNewswire Inc.GeneDx to Report Third Quarter 2023 Financial Results on Monday, October 30, 2023NASDAQ:WGSGeneDx Holdings Corporation
11/09/202307:00GlobeNewswire Inc.GeneDx Announces Evolution of Executive Leadership TeamNASDAQ:WGSGeneDx Holdings Corporation
06/09/202307:00GlobeNewswire Inc.GeneDx Announces Industry-Leading Accomplishment of 500,000 Clinical Exomes SequencedNASDAQ:WGSGeneDx Holdings Corporation
21/08/202306:00GlobeNewswire Inc.GeneDx Announces Data Demonstrating that Whole Exome and Genome Sequencing Report Fewer Variants of Uncertain Significance (VUS) than Multi-Gene Panel Testing Published in Genetics in MedicineNASDAQ:WGSGeneDx Holdings Corporation
08/08/202315:20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:WGSGeneDx Holdings Corporation
08/08/202315:05GlobeNewswire Inc.GeneDx Reports Second Quarter 2023 Financial Results and Business HighlightsNASDAQ:WGSGeneDx Holdings Corporation
07/08/202307:00PR Newswire (US)PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal CareNASDAQ:WGSGeneDx Holdings Corporation
19/07/202306:05GlobeNewswire Inc.GeneDx and Prognos Health Announce Strategic Partnership to Help Rare Disease Patients More Rapidly Gain Access to Potential Treatment OptionsNASDAQ:WGSGeneDx Holdings Corporation
18/07/202315:05GlobeNewswire Inc.GeneDx to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023NASDAQ:WGSGeneDx Holdings Corporation
28/06/202306:00GlobeNewswire Inc.GeneDx to Present New Data on Urine Mitochondrial DNA Testing at the 2023 United Mitochondrial Disease Foundation’s Mitochondrial Medicine SymposiumNASDAQ:WGSGeneDx Holdings Corporation
 Showing the most relevant articles for your search:NASDAQ:WGS

Su Consulta Reciente

NASDAQ
ECPG
Encore Capital
TG
WELN
Amundi Index Solutions
AMEX
KBE
SPDR S&P Bank
NYSE
GCT
Gmh Communities Trst
BIT
F37674
Vontobel Financial Produ...
COIN
LABTC
LAToken
USOTC
GLIOF
Panther Minerals (PK)
DGFX
LILFLOKIUSDT
Lil Floki
TSX
RIIN
Russell Investments Glob...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados